From USnews.com….
The director of Chile’s health regulator said he sees no evidence of safety issues with Sputnik V, the COVID-19 vaccine developed in Russia, despite its rejection by the Brazilian health regulator this week over a lack of information about its safety.
Heriberto Garcia, the director of Chile’s Public Health Institute (ISP), said Chile was seeking clarity from the vaccine’s developers about the potential presence of an adenovirus that could reproduce, possibly creating a negative reaction in recipients. This was the basis for Brazil’s health regulator, Anvisa, rejecting the vaccine on Monday.
But he added that real-world data from Argentina and Mexico, where Sputnik V is already being rolled out, showed instances of significant effects among recipients of the vaccine were no greater than those among Chilean citizens who have received the Pfizer-BioNTech or Sinovac equivalents.
He said that even if Sputnik V’s developers supplied information suggesting the presence of “replication-competent adenoviruses” (RCA), the ISP would not necessarily reject it.
